P1-253: Quality of life (QOL) evaluation for advanced non-small cell lung cancer (NSCLC): a comparison between vinorelbine and gemcitabine followed by docetaxel (VGD) versus paclitaxel and carboplatin (PC) regimen on a phase III protocol JMTO LC00-03 (BRI LC03-01)

Authors :: Masanori Fukushima
Harue Tada
Tetsu Shinkai
Kaoru Kubota
Akihiro Tokoro
Masaaki Kawahara
Kiyoyuki Furuse
Satoshi Teramukai
Ryota Ishiwata
Source :: Journal of Thoracic Oncology. (8):S839
Publisher :: International Association for the Study of Lung Cancer. Published by Elsevier Inc.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
non-small cell lung cancer (NSCLC)
Phase III Protocol
medicine.disease
Vinorelbine
Carboplatin
Gemcitabine
chemistry.chemical_compound
chemistry
Paclitaxel
Docetaxel
Quality of life
Internal medicine
medicine
business
medicine.drug

Full Text Access

Tools